What is AXT's latest dividend and current dividend yield?

What is AXT's gross profit margin?

What were the key takeaways from AXT’s earnings call?

Did AXT beat or miss consensus estimates last quarter?

What guidance did AXT's management provide for the next earnings period?

What is the revenue and EPS growth rate for AXT year over year?

What does AXT do and what are its main business segments?

What factors drove the changes in AXT's revenue and profit?

- **Revenue Growth**: Q1 2026 guided to $26M, up from $23.1M in Q4, driven by indium phosphide for AI data centers in China.
- **Capacity Expansion**: 25% increase in Q4, targeting double capacity by end-2026 ($30M capex). 6-inch wafer development underway.
- **Risk Factor**: Export permits remain gating factor, with $26M Q1 revenue secured but upside dependent on approvals.
- **Profitability**: Gross margin target 35%+ with higher indium phosphide shipments. Inventory reduction and cost control key priorities.

**【CFO Financial Commentary】**
- Q4 2025 revenue: $23.1 million (down 18% QoQ, up 8% YoY). Indium phosphide ($8M), gallium arsenide ($7M), germanium ($0.23M), raw materials ($7.6M). 81.5% of revenue from Asia-Pacific.
- Non-GAAP gross margin: 21.5% (up from 18% YoY). GAAP gross margin: 20.9%.
- Operating expenses: $7.8M (up 20% QoQ, down 22% YoY). Non-GAAP net loss: $2.6M ($0.06/share). Cash: $128.4M (up $97.2M from stock offering). Inventory: $81.7M (up $4M QoQ).

**【CEO Business Update】**
- Q1 2026 revenue expected to grow sequentially, driven by indium phosphide for AI data centers. Backlog: $60M (up from $49M). China data center revenue +60% QoQ.
- Capacity increased by 25% in Q4, aiming to double by end-2026. Gallium arsenide demand for VCSELs in China's automotive/robotics sectors. Raw material subsidiary JinMei now refining indium.

**【CFO Guidance】**
- Q1 2026: $26M revenue (confirmed shipments), potential upside with permits. Non-GAAP net loss: $0.02-$0.04/share. OpEx: $9M. Shares: 53.2M.

**【Q&A Highlights】**
- Export permits unpredictable, but $26M Q1 revenue secured. Backlog visibility extends 6 months post-permit approval. 6-inch wafer development ongoing, targeting 35%+ gross margin with scale. China's AI infrastructure build-out driving demand, with Tongmei IPO in process for domestic supply chain control.

AXT, Inc. (AXTI) Q4 2025 Earnings Call Transcript

- **Record Backlog Growth**: $49M indium phosphide backlog, up 125% QoQ, driven by AI data center demand and longer-term customer orders.
- **Revenue Recovery**: Q3 revenue $28M (15% YoY growth), with indium phosphide revenue at 5-year high. Non-GAAP gross margin 22.4%, up 14.2% YoY.
- **Export Permit Challenge**: 60-day permit processing time limits visibility, but customers adapting with 6-month order windows.
- **Capacity Expansion**: Current indium phosphide capacity $20M/Q, scalable to $25M in 3 months; doubling possible in 9 months with $10M-$15M investment.
- **Profitability Path**: Gross margin improvement achievable with higher utilization, but Q4 net loss expected ($0.01-$0.03/share) due to permit delays.
- **Strategic Shift**: Shifting focus from PON to data centers in China, with germanium substrates de-emphasized due to margin constraints.


**【CFO Financial Commentary】**
- Q3 2025 revenue: $28.0 million (15% YoY growth, 56% sequential increase). Indium phosphide ($13.1M), gallium arsenide ($7.5M), germanium ($0.6M), and raw materials ($6.7M) drove growth. 87% of revenue came from Asia Pacific.
- Non-GAAP gross margin improved to 22.4% (vs. 8.2% Q2 2025, 24.3% Q3 2024), driven by higher volume and better product mix.
- Operating expenses: $6.7M (down 12% YoY, 11% QoQ). Non-GAAP net loss: $1.2M ($0.03/share), narrower than Q2 ($6.4M loss).
- Cash: $31.2M (down $3.9M). Inventory: $77.7M (down $2.4M).

**【CEO Business Summary】**
- Indium phosphide revenue at highest level since 2022, with $49M backlog (permit-dependent). Export permits take ~60 days; customers now place longer-term orders (e.g., 12 shipments over 6 months).
- Data center demand (AI infrastructure) driving growth, with U.S. hyperscalers and China buildouts as key markets. China's data center expansion surpassing PON as primary application.
- Gallium arsenide revenue up 20% QoQ, driven by semi-insulating wafers for RF devices. Germanium substrates underperform due to low gross margins.
- Raw materials business stable, with focus on earth materials supply chain.

**【Q4 2025 Guidance】**
- Revenue: $27M-$30M (includes $20M with permits, $7M-$10M potential from backlog). Non-GAAP net loss: $0.01-$0.03/share. OpEx: ~$9M.
- Capacity: Current indium phosphide capacity ~$20M/Q, scalable to +25% in 3 months, doubling possible in 9 months with $10M-$15M investment.

**【Q&A Highlights】**
- **Customer Behavior**: New customers (Tier 1 optical transceiver makers) qualifying AXT due to low EPD wafers. Orders reflect 6-month visibility, with permits as gating factor.
- **Profitability**: Gross margin improvement possible with higher utilization, but permit delays limit predictability. ASPs stable, with premium pricing for high-quality indium phosphide.
- **Geopolitical Impact**: U.S. AI infrastructure spend and China's data center buildouts driving demand. Permit process complexity may lead to inventory builds by customers.
- **Capacity Expansion**: U.S.-based manufacturing considered for long-term growth, but China remains key for near-term scalability.


AXT, Inc. (AXTI) Q3 2025 Earnings Call Transcript

- **Revenue decline with margin recovery**: Q2 revenue down 35% YoY, but non-GAAP gross margin improved to 8.2% from -6.1% Q1.
- **$10M backlog constrained by permits**: Export delays caused 50% of Q2 shortfall; 700K indium phosphide shipped, more permits expected in Q3.
- **AI-driven growth in China**: Indium phosphide revenue nearly doubled in China for AI-related applications; 40% global market share.
- **Q3 outlook**: Revenue $19-21 million, non-GAAP net loss $0.11-$0.13, gross margin improving to mid-teens.

**【CFO Financial Commentary】**
- Q2 2025 revenue: $18.0 million (down 7.8% QoQ, 35.4% YoY). Product breakdown: indium phosphide ($3.6M), gallium arsenide ($6.2M), germanium ($1.5M), joint ventures ($6.7M). 90% of revenue from Asia Pacific.
- Non-GAAP gross margin: 8.2% (vs. -6.1% Q1, 27.6% Q2 2024). GAAP gross margin: 8.0%.
- Operating expenses: $7.6 million (non-GAAP, down 11% QoQ). Net loss: $6.4 million (non-GAAP, $0.15/share).
- Cash: $35.1 million (down $3.1M QoQ). Inventory: $80.1 million (down $300K).
- Tongmei IPO: Still in process on STAR Market.

**【CEO Business Update】**
- Export permit delays caused 50% of Q2 shortfall. Q2 gallium arsenide revenue growth slower than expected due to processing times.
- Gross margin improvement driven by manufacturing efficiency. Indium phosphide revenue nearly doubled in China for AI-related applications.
- Backlog of $10 million for gallium arsenide and indium phosphide. Q3 revenue guidance: $19-21 million, with gross margin in low mid- to mid-teens.
- Germanium revenue growth in satellite solar cells, but Q3 sales expected to decline due to permit challenges.

**【Q&A Highlights】**
- Permit progress: 700K indium phosphide shipped in Q2, additional permits in July. Backlog of $10 million remains.
- Market demand: Indium phosphide at 40% global market share, driven by AI and data center connectivity. Gallium arsenide wireless business resuming cautiously.
- Inventory: No significant build-up; customers awaiting permits.

**【Management Closing】**
- Upcoming participation in Needham Virtual Semiconductor & SemiCap Conference in August.

AXT, Inc. (AXTI) Q2 2025 Earnings Call Transcript

- **Q1 2025 Results**: Revenue $19.4M (-27% YoY), negative gross margin (-6.1%) due to GaAs yield issues and export restrictions
- **Key Initiatives**: 
  - China data center growth (Q2 revenue +10x Q1)
  - Lidar for EVs with low-EPD GaAs substrates
  - $M+ indium phosphide backlog awaiting permits
- **Gross Margin Outlook**: Target 10% in Q2, improving to mid-teens by year-end
- **Risks**: Tariffs on U.S. sales (25%), geopolitical export restrictions
- **Liquidity**: $38.2M cash, inventory down $4.7M to $80.4M

**【CFO Financial Commentary】**
- Q1 2025 revenue: $19.4 million (YoY -27.3%, QoQ -22.7%). Indium phosphide: $3.8M, gallium arsenide: $6.7M, germanium: $0.6M. 83% of revenue from Asia Pacific.
- Non-GAAP gross margin: -6.1% (Q4 2024: 17.9%, Q1 2024: 27.3%). Key drivers: 
  1. Yield issues in semi-insulating GaAs wafers for HPT wireless market
  2. Revenue mix shift to lower-margin joint venture sales
  3. Under-absorbed factory overhead
- Operating expenses: $8.5M (YoY -2.3%, QoQ -19%). Non-GAAP net loss: $8.2M ($0.19/share)
- Cash: $38.2M (up $4.4M). Inventory: $80.4M (down $4.7M)

**【CEO Business Update】**
- **Export restrictions**: Indium phosphide exports to non-China customers halted since Feb 4. $M+ backlog awaiting permits. Expected first shipments mid-June
- **China growth opportunities**: 
  - Data center optical interconnect market: Q2 revenue growth >10x Q1
  - Lidar for EVs: Low-EPD GaAs substrates gaining traction
  - PON lasers: China demand strong
- **Gallium arsenide recovery**: HPT wireless market opportunity, but production scaled back to fix yields. Target: 10%+ gross margin in Q2
- **Joint ventures**: Raw material sales up 12% YoY. Expanding into new markets like PBM crucibles

**【Q&A Highlights】**
- **Gross margin recovery**: Target 10% in Q2, improving to mid-teens by year-end
- **Indium phosphide permits**: Applications submitted for all major customers. Initial shipments likely Q3
- **Tariffs**: 25% Section 201 tariffs apply to U.S. sales. No immediate resolution, but working on solutions
- **Wireless market**: $1M+ quarterly opportunity with one large customer. Yield issues resolved, but production ramping cautiously

AXT (AXTI)-1 May 25-2025 Q1 Earnings call transcript

- **Revenue Growth**: 31% YoY to $99.4M, driven by AI, data center, and wireless market expansion.
- **Innovation Lead**: Industry-leading low EPD InP substrates for next-gen EML lasers, with major customer qualification in 2026.
- **Wireless Market Surge**: GaAs HBT market share jumps to 10%, targeting 30%+ growth in 2025 with 8-inch process improvements.
- **China Export Challenge**: $4-5M Q1 revenue delay from InP export permits, but confident in efficient approval process.
- **Gross Margin Recovery**: Q1 2025 gross margin ~17-18%, improving to mid-20s by Q2 with normalized production.

**【CEO Business Overview】**
- **2024 Year-on-Year Growth**: Revenue increased 31% to $99.4 million, driven by demand recovery in cloud, data center, and wireless markets.
- **Key Product Developments**: Launched 8-inch GaAs and 6-inch InP substrates, achieving breakthroughs in low EPD (defect density) materials critical for AI and high-speed optical interconnects.
- **Market Challenges**: Faced $4-5 million Q1 revenue delay due to China's new InP export restrictions, similar to prior GaAs restrictions. 40% of InP revenue comes from China, but no military applications involved.
- **2025 Growth Drivers**: 
  1. **AI & Data Centers**: Transition to 100G+ VCSELs and 800G/1.6T silicon photonics, with leading low EPD InP substrates for EML lasers.
  2. **Wireless Market**: GaAs HBT market share expanded to 10%, targeting 30%+ growth in 2025 with 8-inch process improvements.
  3. **Passive Optical Networks**: Recovering demand in China, with low inventory levels.

**【CFO Financial Highlights】**
- **Q4 2024 Results**: 
  - Revenue: $25.1 million (15% YoY growth)
  - Non-GAAP Gross Margin: 17.9% (down 640bps YoY due to lower recycling benefits and under-absorbed overhead)
  - Non-GAAP Net Loss: $4.3 million (vs. $2.1M Q3)
- **Full Year 2024**: 
  - Revenue: $99.4 million (+31% YoY)
  - Non-GAAP Gross Margin: 24.3% (vs. 18.1% prior year)
  - Non-GAAP Net Loss: $8.5 million (vs. $14.3M prior year)
- **Cash Position**: $33.8 million as of Dec 31, down $5M from Q3 due to non-cash expenses and loan repayments.

**【Q&A Key Takeaways】**
1. **Gross Margin Recovery**: Expect Q1 2025 gross margin to remain low (~17-18%) due to InP export delays, but improving to mid-20s by Q2 and beyond.
2. **R&D Investment**: Continued focus on low EPD InP for EML lasers, with major customer qualification expected for 2026 deployment.
3. **Wireless Market Outlook**: Target 30%+ growth in GaAs HBT revenue in 2025, leveraging 8-inch process improvements and China wireless infrastructure expansion.
4. **Export Permit Process**: Similar to GaAs experience, expect 40-45 day approval times for InP exports, with first applications submitted by early March.
5. **Germanium Strategy**: Temporarily idled due to raw material price volatility, but monitoring for potential restart opportunities.


Actual											-0.01	0.01	0.02	0.05	0.08	0.1	0.09	0.07	0.07	0.13	0.13	0.05	-0.06	-0.1	-0.12	-0.07	-0.03	-0.02	-0.05	-0.1	-0.19	-0.15	-0.03	-0.05
Forecast											-0.0473	-0.0083	0.01	0.0285	0.0543	0.0849	0.105	0.0625	0.0633	0.0774	0.0872	0.0245	-0.102	-0.0989	-0.1132	-0.1316	-0.078	-0.0465	-0.0595	-0.0419	-0.1371	-0.1333	-0.1186	-0.0576
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+78.86%	+220.48%	+100.00%	+75.44%	+47.33%	+17.79%	-14.29%	+12.00%	+10.58%	+67.96%	+49.08%	+104.08%	+41.18%	-1.11%	-6.01%	+46.81%	+61.54%	+56.99%	+15.97%	-138.66%	-38.58%	-12.53%	+74.70%	+13.19%

AXTI

AXTI fundamentals

AXTI Q4 2025 Earnings

Earnings Call

You can ask Aime

AXTI

AXTI fundamentals

AXTI Q4 2025 Earnings

Earnings Call

AXTI Earnings Call Summary for Q4/20254:30 PM on Feb 19, 2026

AXTI Earnings Call Summary for Q3/20254:30 PM on Oct 30, 2025

AXTI Earnings Call Summary for Q2/20254:30 PM on Jul 31, 2025

AXTI Earnings Call Summary for Q1/20254:30 PM on May 1, 2025

AXTI Earnings Call Summary for Q4/20244:30 PM on Feb 20, 2025

You can ask Aime